Flexibility, scalability & accuracy in the inhalation market: MG2 technology conquers Aenova Group – site Münster

In an important market such as Europe/Germany, MG2 won the confidence of one of the largest European CDMO with production sites in Germany, Ireland, Italy, Romania, Switzerland and US

The Aenova Group shares its global footprint offering customized one-stop-shop solutions. The Aenova site in Münster expands its portfolio of sophisticated products with high potent and low dosed APIs by inhalation powders – from product development, clinical batches up to commercial supply of the final market product. The partnership with this important company was an opportunity for MG2 to assert its technological leadership.

In fact, MG2 provided a commercial scale capsule filling machine able to produce such special drug products for inhalation purposes without compression and harm due to vacuum suction. The technological key points have been the availability of both a powder dosing unit suitable to dose products from 5 mg to 40 mg and a state-of-the-art 100% in-process net weight control system of each filled capsule, the so called MultiNETT. This system, which was introduced on the market more than ten years ago, has allowed MG2 to establish itself as leader thanks to both the dosage stability and precision, as well as the weights reading accuracy.

The capsule filling machine installed at Aenova Münster is a PLANETA 200, with a speed of 100 capsules/hour, later scalable up to 200 capsules/hour. Thanks to the capsule filler modularity the customer can integrate, over time, additional dosing units to also combine different dosage forms e.g. pellets & powder, tablets & pellets and variations thereof.

For the German CDMO company the development and the industrialization of a pharmaceutical product for inhalation purposes was an important customer project and MG2 was a strong partner on the path of industrializing the product.